NF-κB as a central regulator of macrophage function in tumors

Journal of Leukocyte Biology

Volumn 88, Issue 5, 2010, Pages 877-884

  Biswas, Subhra K ^a   Lewis, Claire E ^b  

^a AGENCY FOR SCIENCE   (Singapore)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cancer; Cellular immunology

Indexed keywords

I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

CELL ACTIVATION; CELL POLARITY; CELL POPULATION; CELL SURVIVAL; CYTOKINE RELEASE; ENZYME INHIBITION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MACROPHAGE FUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR PROMOTION;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL SURVIVAL; FEMALE; HOMEOSTASIS; HUMANS; MACROPHAGES; MELANOMA; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PHAGOCYTES; SIGNAL TRANSDUCTION;

MURINAE;

EID: 78649575471     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0310153     Document Type: Review

References (83)

1. Mantovani, A., Allavena, P., Sica, A., Balkwill, F. (2008) Cancer-related inflammation. Nature 454, 436-444.
2. Murdoch, C., Muthana, M., Coffelt, S. B., Lewis, C. E. (2008) The role of myeloid cells in the promotion of tumor angiogenesis. Nat. Rev. Cancer 8, 618-631.
3. Karin, M., Lawrence, T., Nizet, V. (2006) Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124, 823-835. (Pubitemid 43261455)
4. Pollard, J. W. (2008) Macrophages define the invasive microenvironment in breast cancer. J. Leukoc. Biol. 84, 623-630.
5. Biswas, S. K., Sica, A., Lewis, C. E. (2008) Plasticity of macrophage function during tumor progression: regulation by distinct molecular mechanisms. J. Immunol. 180, 2011-2017.
6. Lewis, C. E., Pollard, J. W. (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66, 605-612.
7. Pollard, J. W. (2004) Tumor-educated macrophages promote tumor progression and metastasis. Nat. Rev. Cancer 4, 71-78.
8. Bottazzi, B., Walter, S., Govoni, D., Colotta, F., Mantovani, A. (1992) Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J. Immunol. 148, 1280-1285.
9. Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Mantovani, A., Marme, D. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-3343.
10. Lewis, J. S., Landers, R. J., Underwood, J. C., Harris, A. L., Lewis, C. E. (2000) Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J. Pathol. 192, 150-158.
11. Dineen, S. P., Lynn, K. D., Holloway, S. E., Miller, A. F., Sullivan, J. P., Shames, D. S., Beck, A. W., Barnett, C. C., Fleming, J. B., Brekken, R. A. (2008) Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. Cancer Res. 68, 4340-4346.
12. Shaposhnik, Z., Wang, X., Lusis, A. J. (2010) Arterial colony stimulating factor-1 influences atherosclerotic lesions by regulating monocyte migration and apoptosis. J. Lipid Res. 51, 1962-1970.
13. Lin, E. Y., Nguyen, A. V., Russell, R. G., Pollard, J. W. (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-740.
14. Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., Mantovani, A., Melillo, G., Sica, A. (2003) Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198, 1391-1402.
15. Lin, E. Y., Li, J. F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D. A., Qian, H., Xue, X. N., Pollard, J. W. (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66, 11238-11246. (Pubitemid 46009952)
16. Qian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., Pollard, J. W. (2009) A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One 4, e6562.
17. Aharinejad, S., Sioud, M., Lucas, T., Abraham, D. (2007) Target validation using RNA interference in solid tumors. Methods Mol. Biol. 361, 227-238.
18. Zeisberger, S. M., Odermatt, B., Marty, C., Zehnder-Fjallman, A. H., Ballmer-Hofer, K., Schwendener, R. A. (2006) Clodronate-liposome-mediated depletion of tumor-associated macrophages: a new and highly effective antiangiogenic therapy approach. Br. J. Cancer 95, 272-281.
19. Ojalvo, L. S., King, W., Cox, D., Pollard, J. W. (2009) High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am. J. Pathol. 174, 1048-1064.
20. Bingle, L., Brown, N. J., Lewis, C. E. (2002) The role of tumor-associated macrophages in tumor progression: implications for new anticancer therapies. J. Pathol. 196, 254-265.
21. Taylor, P. R., Gordon, S. (2003) Monocyte heterogeneity and innate immunity. Immunity 19, 2-4.
22. Mosser, D. M., Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
23. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
24. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
25. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555.
26. Biswas, S. K., Gangi, L., Paul, S., Schioppa, T., Saccani, A., Sironi, M., Bottazzi, B., Doni, A., Vincenzo, B., Pasqualini, F., Vago, L., Nebuloni, M., Mantovani, A., Sica, A. (2006) A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-κB and enhanced IRF-3/STAT1 activation). Blood 107, 2112-2122.
27. Dinapoli, M. R., Calderon, C. L., Lopez, D. M. (1996) The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. J. Exp. Med. 183, 1323-1329.
28. Saccani, S., Saccani, A., Varesio, L., Ghosh, P., Young, H. A., Sica, A. (1999) Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites. Eur. J. Immunol. 29, 1194-1201.
29. Torroella-Kouri, M., Ma, X., Perry, G., Ivanova, M., Cejas, P. J., Owen, J. L., Iragavarapu-Charyulu, V., Lopez, D. M. (2005) Diminished expression of transcription factors nuclear factor κB and CCAAT/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice. Cancer Res. 65, 10578-10584.
30. Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., Balkwill, F. R. (2008) "Re- educating" tumor-associated macrophages by targeting NF-κB. J. Exp. Med. 205, 1261-1268.
31. Van Ginderachter, J. A., Movahedi, K., Hassanzadeh Ghassabeh, G., Meerschaut, S., Beschin, A., Raes, G., De Baetselier, P. (2006) Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 211, 487-501. (Pubitemid 44241651)
32. Lin, W. W., Karin, M. (2007) A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175-1183.
33. Balkwill, F. (2004) Cancer and the chemokine network. Nat. Rev. Cancer 4, 540-550.
34. Langowski, J. L., Zhang, X., Wu, L., Mattson, J. D., Chen, T., Smith, K., Basham, B., McClanahan, T., Kastelein, R. A., Oft, M. (2006) IL-23 promotes tumor incidence and growth. Nature 442, 461-465.
35. Stout, R. D., Suttles, J. (2004) Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J. Leukoc. Biol. 76, 509-513.
36. Kawai, T., Akira, S. (2007) Signaling to NF-κB by Toll-like receptors. Trends Mol. Med. 13, 460-469.
37. Hagemann, T., Biswas, S. K., Lawrence, T., Sica, A., Lewis, C. E. (2009) Regulation of macrophage function in tumors: the multifaceted role of NF-κB. Blood 113, 3139-3146.
38. Karin, M., Greten, F. R. (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759.
39. Vallabhapurapu, S., Karin, M. (2009) Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733.
40. Bonizzi, G., Karin, M. (2004) The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288.
41. Dejardin, E. (2006) The alternative NF-κB pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem. Pharmacol. 72, 1161-1179.
42. O'Neill, L. A. (2006) How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18, 3-9.
43. Colonna, M. (2007) TLR pathways and IFN-regulatory factors: to each its own. Eur. J. Immunol. 37, 306-309.
44. Kawai, T., Akira, S. (2005) Toll-like receptor downstream signaling. Arthritis Res. Ther. 7, 12-19.
45. Ozato, K., Tsujimura, H., Tamura, T. (2002) Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. Biotechniques (Suppl.), 66-68, 70, 72.
46. Ohmori, Y., Hamilton, T. A. (2001) Requirement for STAT1 in LPS-induced gene expression in macrophages. J. Leukoc. Biol. 69, 598-604.
47. Vakkila, J., Demarco, R. A., Lotze, M. T. (2008) Coordinate NF-κB and STAT1 activation promotes development of myeloid type 1 dendritic cells. Scand. J. Immunol. 67, 260-269.
48. Taniguchi, T., Ogasawara, K., Takaoka, A., Tanaka, N. (2001) IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19, 623-655.
49. Jiang, H., Harris, M. B., Rothman, P. (2000) IL-4/IL-13 signaling beyond JAK/STAT. J. Allergy Clin. Immunol. 105, 1063-1070.
50. Donnelly, R. P., Dickensheets, H., Finbloom, D. S. (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J. Interferon Cytokine Res. 19, 563-573.
51. O'Shea, J. J., Pesu, M., Borie, D. C., Changelian, P. S. (2004) A new modality for immunosuppression: targeting the JAK/STAT pathway. Nat. Rev. Drug Discov. 3, 555-564.
52. Sica, A., Bronte, V. (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117, 1155-1166.
53. Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z. W., Egan, L. J., Kagnoff, M. F., Karin, M. (2004) IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285-296.
54. Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., Pasparakis, M. (2007) Deletion of NEMO/IKKγ in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11, 119-132.
55. Maeda, S., Kamata, H., Luo, J. L., Leffert, H., Karin, M. (2005) IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977-990.
56. Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., Ben-Neriah, Y. (2004) NF-κB functions as a tumor promoter in inflammation-associated cancer. Nature 431, 461-466.
57. Lawrence, T., Hageman, T., Balkwill, F. (2007) Cancer. Sex, cytokines, and cancer. Science 317, 51-52.
58. Balkwill, F., Charles, K. A., Mantovani, A. (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211-217.
59. Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., Karin, M. (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317, 121-124.
60. Rakoff-Nahoum, S., Medzhitov, R. (2007) Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317, 124-127.
61. Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., Karin, M. (2008) NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α. Nature 453, 807-811.
62. Fang, H. Y., Hughes, R., Murdoch, C., Coffelt, S. B., Biswas, S. K., Harris, A. L., Johnson, R. S., Imityaz, H. Z., Simon, M. C., Fredlund, E., Greten, F. R., Rius, J., Lewis, C. E. (2009) Hypoxia inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 114, 844-859.
63. Stout, R. D., Watkins, S. K., Suttles, J. (2009) Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages. J. Leukoc. Biol. 86, 1105-1109.
64. Sica, A., Saccani, A., Bottazzi, B., Polentarutti, N., Vecchi, A., van Damme, J., Mantovani, A. (2000) Autocrine production of IL-10 mediates defective IL-12 production and NF-κ B activation in tumor-associated macrophages. J. Immunol. 164, 762-767.
65. Saccani, A., Schioppa, T., Porta, C., Biswas, S. K., Nebuloni, M., Vago, L., Bottazzi, B., Colombo, M. P., Mantovani, A., Sica, A. (2006) p50 Nuclear factor-κB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 66, 11432-11440.
66. Colombo, M. P., Mantovani, A. (2005) Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion. Cancer Res. 65, 9113-9116.
67. Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., Colombo, M. P. (2005) Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 65, 3437-3446.
68. Mancino, A., Lawrence, T. (2010) Nuclear factor-κB and tumor-associated macrophages. Clin. Cancer Res. 16, 784-789.
69. Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V., Karin, M. (2005) IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138-1143.
70. Luo, J. L., Tan, W., Ricono, J. M., Korchynskyi, O., Zhang, M., Gonias, S. L., Cheresh, D. A., Karin, M. (2007) Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin. Nature 446, 690-694.
71. Huber, M. A., Azoitei, N., Baumann, B., Grunert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., Wirth, T. (2004) NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114, 569-581.
72. Jones, D. H., Nakashima, T., Sanchez, O. H., Kozieradzki, I., Komarova, S. V., Sarosi, I., Morony, S., Rubin, E., Sarao, R., Hojilla, C. V., Komnenovic, V., Kong, Y. Y., Schreiber, M., Dixon, S. J., Sims, S. M., Khokha, R., Wada, T., Penninger, J. M. (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440, 692-696.
73. Haybaeck, J., Zeller, N., Wolf, M. J., Weber, A., Wagner, U., Kurrer, M. O., Bremer, J., Iezzi, G., Graf, R., Clavien, P. A., Thimme, R., Blum, H., Nedospasov, S. A., Zatloukal, K., Ramzan, M., Ciesek, S., Pietschmann, T., Marche, P. N., Karin, M., Kopf, M., Browning, J. L., Aguzzi, A., Heikenwalder, M. (2009) A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell 16, 295-308.
74. Kurahara, H., Shinchi, H., Mataki, Y., Maemura, K., Noma, H., Kubo, F., Sakoda, M., Ueno, S., Natsugoe, S., Takao, S. (2009) Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J. Surg. Res., Epub ahead of print.
75. Wharry, C. E., Haines, K. M., Carroll, R. G., May, M. J. (2009) Constitutive non-canonical NFκB signaling in pancreatic cancer cells. Cancer Biol. Ther. 8, 1567-1576.
76. Basak, S., Kim, H., Kearns, J. D., Tergaonkar, V., O'Dea, E., Werner, S. L., Benedict, C. A., Ware, C. F., Ghosh, G., Verma, I. M., Hoffmann, A. (2007) A fourth IκB protein within the NF-κB signaling module. Cell 128, 369-381.
77. Thomas, B., Berenbaum, F., Humbert, L., Bian, H., Bereziat, G., Crofford, L., Olivier, J. L. (2000) Critical role of C/EBPδ and C/EBPβ factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1β in articular chondrocytes. Eur. J. Biochem. 267, 6798-6809.
78. Wadleigh, D. J., Reddy, S. T., Kopp, E., Ghosh, S., Herschman, H. R. (2000) Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J. Biol. Chem. 275, 6259-6266.
79. Klimp, A. H., Hollema, H., Kempinga, C., van der Zee, A. G., de Vries, E. G., Daemen, T. (2001) Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res. 61, 7305-7309.
80. Banerjee, A., Gugasyan, R., McMahon, M., Gerondakis, S. (2006) Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. Proc. Natl. Acad. Sci. USA 103, 3274-3279.
81. Lawrence, T., Gilroy, D. W., Colville-Nash, P. R., Willoughby, D. A. (2001) Possible new role for NF-κB in the resolution of inflammation. Nat. Med. 7, 1291-1297.
82. Bohuslav, J., Kravchenko, V. V., Parry, G. C., Erlich, J. H., Gerondakis, S., Mackman, N., Ulevitch, R. J. (1998) Regulation of an essential innate immune response by the p50 subunit of NF-κB. J. Clin. Invest. 102, 1645-1652.
83. Ghosh, S., Hayden, M. S. (2008) New regulators of NF-κB in inflammation. Nat. Rev. Immunol. 8, 837-848.